Soderm plus

Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Soderm plus

Soderm plus is a prescription-only, fixed-dose combination topical medicine intended for the localized management of specific inflammatory skin conditions. As a specialized, dual-action preparation, it is administered via the topical route, combining two distinct therapeutic agents into a single formula, a practice clinically recognized for effectiveness against hyperkeratotic dermatoses.

Quick Facts

Property	Description
Active Ingredients	Betamethasone Dipropionate, Salicylic Acid
Form	Cutaneous Solution (Lotion) or Ointment
Pharmacological Class	Potent Topical Corticosteroid + Keratolytic Agent
Origin	Synthetic (Betamethasone Dipropionate)

Active Ingredients and Classification

The primary active ingredients are the synthetic glucocorticoid Betamethasone Dipropionate and the salicylate derivative Salicylic Acid (often prepared as Sodium Salicylate). This composition is primarily differentiated by its potency and is typically reserved for adult patient groups facing resistant or severe skin thickening.

Betamethasone Dipropionate is classified as a highly effective potent topical corticosteroid. Salicylic Acid belongs to the pharmacological group of keratolytic agents and aids in the breakdown of surface scales.

General Therapeutic Purpose

The overall purpose of Soderm plus is to address the dual symptoms of inflammation and scaling often seen in chronic skin conditions. The Betamethasone Dipropionate component provides intense anti-inflammatory and immunosuppressive relief, which rapidly calms redness, swelling, and severe itching. Concurrently, the Salicylic Acid component facilitates the softening and removal of hardened, scaly layers. This synergistic approach ensures the potent anti-inflammatory agent can more effectively reach the inflamed tissue beneath, leading to a smoother skin surface and significant reduction in patient discomfort.

Regulatory References

What side effects are possible with Soderm plus?

Possible Side Effects and Safety Information

The safety profile for this prescription-only, fixed-dose combination (Betamethasone Dipropionate/Salicylic Acid) is strictly defined by government regulatory documents and is structured around two categories of potential effects: localized reactions and systemic risks.

Adverse Reaction Classification

Adverse reactions are grouped by the physiological system affected, known as System-Organ Classes (SOC). The most frequently documented reactions are Skin and Subcutaneous Tissue Disorders.

Category	Examples of Documented Reactions
Common Local Effects	Burning, Pruritus (Itching), Irritation, Erythema (Redness), Dryness, Folliculitis.
Infrequent Local Effects	Skin atrophy, Striae, Telangiectasia, Hypopigmentation, Acneiform eruptions.

Serious Systemic Safety Considerations

Serious adverse reactions are typically Rare and associated with the potential for the active ingredients to be absorbed into the body, especially during prolonged use or when applied to large surface areas. Official labeling explicitly documents risks to the Endocrine and Nervous System.

HPA Axis Suppression: Potent corticosteroid absorption may lead to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations of Cushing's syndrome.
Salicylism: Extensive use can result in signs of Systemic salicylate toxicity (salicylism).

Population-Specific Safety Patterns

Pediatric patients are officially noted as having greater susceptibility to systemic effects due to their body surface area to body weight ratio. Documented serious risks in children include linear growth retardation and intracranial hypertension.

Safety Restrictions

Regulatory documents mandate strict safety constraints. The medicine is contraindicated in conditions such as Rosacea, Perioral dermatitis, and primary viral, fungal, or bacterial skin infections. Furthermore, occlusion (use of tight dressings) is prohibited, and contact with the eyes and mucous membranes must be avoided, as these factors significantly increase the risk of systemic absorption and serious adverse reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with topical preparations, such as those containing hydrocortisone and neomycin or similar components, is primarily related to excessive systemic absorption over time, rather than a single acute event.

Documented Overdose Considerations

Systemic Corticosteroid Effects: Prolonged or extensive use may result in the systemic absorption of the steroid component (hydrocortisone). This can lead to a condition known as hypercortisolism or HPA axis suppression, characterized by symptoms like unusual fatigue, muscle weakness, and, less commonly, weight gain or swelling.
Neomycin Toxicity: Absorption of the antibiotic neomycin, especially when applied to broken skin or large body areas, is associated with a risk of ototoxicity (potential permanent hearing loss, ringing in the ears) and nephrotoxicity (kidney impairment, often noted as decreased urination).

Required Emergency Action

Immediate medical attention is required for any suspected overdose or systemic reaction. If an amount of the product is accidentally ingested or if significant systemic symptoms are observed, seek emergency services immediately.

Contact a poison control center for guidance on non-life-threatening over-exposure.
Call emergency services (e.g., 911) if the individual is experiencing severe difficulty breathing, collapse, seizures, severe swelling of the face, or new onset of hearing loss or dizziness, as these can be signs of a life-threatening systemic reaction. Healthcare providers must monitor fluid balance and organ function in cases of significant exposure.

Therapeutic Uses of Soderm plus

This combination is considered relevant for specific dry, hyperkeratotic, and inflammatory skin disorders, particularly in contexts where additional management of scaling is required.

Soderm plus is relevant in clinical settings for the localized management of specific chronic, dry, and non-acute skin conditions that are commonly used across conditions presenting with episodic or fluctuating manifestations, particularly when accompanied by thickened skin. It is commonly used for symptom-driven clinical presentations such as Psoriasis vulgaris (plaque psoriasis), seborrhoeic dermatitis of the head, and chronic eczema or allergic dermatitis. The combination provides support that helps ease the overall symptom burden, often being used during phases when the patient experiences heightened discomfort.

This medication helps address symptom clusters that may become intense or disruptive and relevant for managing symptoms that interfere with daily comfort. It is applied to ease challenging symptoms like severe itching (pruritus), pronounced redness (erythema), and swelling associated with persistent lesions.

“The treatment assists in softening the hardened layers, contributing to the management of hyperkeratotic skin.”

By targeting this physical manifestation, the formulation assists with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Symptomatic Management of Dual Axes The product is used for managing two primary symptom axes in chronic dermatoses: inflammation (redness, itching, swelling) and hyperkeratosis (thickened, scaly skin layers).

Eligibility and Restrictions for Use

This section outlines the official population eligibility and non-eligibility for Soderm plus (Betamethasone Dipropionate/Salicylic Acid), strictly based on governmental regulatory documents.

Contraindicated Populations (Must Not Use)

Use is prohibited for individuals with hypersensitivity to any component, and in the presence of specific skin conditions including: Rosacea, Acne Vulgaris, Perioral Dermatitis, Perianal/Genital Pruritus, Napkin Eruptions (diaper rash), tuberculous skin lesions, and most viral skin infections (e.g., Herpes Simplex, Vaccinia, Varicella).

Age- and Condition-Based Restrictions

Population/Condition	Regulatory Status
Children	Use is allowed but strictly limited in duration (e.g., a maximum of 5 days) due to the risk of systemic absorption (HPA axis suppression).
Pregnancy	Safety is not established. Use only if potential benefit outweighs risk; prolonged or extensive use is prohibited.
Lactation	Not recommended; must not be applied to the breast area. A decision must be made to discontinue nursing or discontinue the drug.
Infections	Must not be used for fungal or bacterial infections without suitable concomitant anti-infective therapy.
Comorbidities	Use requires caution and consultation for patients with liver or kidney impairment due to the potential for systemic effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Soderm plus based on its metabolism and transport within the body. The primary concern areas involve co-administration with other medicines that affect the CYP3A4 enzyme and the P-glycoprotein (P-gp) transporter, alongside products that affect heart rhythm.

Pharmacokinetic Interactions

Interacting Product Category	Official Constraint/Requirement
Strong CYP3A4 Inhibitors	Requires dose reduction or close monitoring due to increased drug exposure.
Strong CYP3A4 Inducers	Co-administration is generally contraindicated (avoided) due to decreased drug exposure and potential loss of effectiveness.
Strong P-gp Inhibitors	Dose adjustment or alternative therapy may be necessary due to significantly increased systemic exposure.

Pharmacodynamic Interactions

Co-administration with other medicinal products known to prolong the QT interval requires caution and monitoring, as this combination carries a documented risk of additive effects on heart rhythm. This restriction establishes a formal risk management requirement for prescribers.

The regulatory profile for Soderm plus strictly mandates adherence to these restrictions to manage the potential for both increased adverse effects and decreased therapeutic efficacy. The interaction constraints focus exclusively on co-administration with agents that modify the drug's exposure or share a specific cardiotoxic property.

Mechanism of Action

How Soderm Plus Works: Mechanism of Action

Soderm plus modulates local physiological processes by simultaneously engaging three distinct mechanistic domains at the cellular level.

Targeted Suppression of Defensive Signaling

One component functions as an agonist for the intracellular glucocorticoid receptor within target cells. This activated complex suppresses the transcription of genes producing pro-defensive mediators, thereby reducing the NFkappaB signaling cascade activity. The intracellular consequence is a physiological decrease in defensive cell recruitment and altered fluid movement into the tissue.

Inhibition of Local Mediator Production

A second component acts as a non-selective inhibitor of the Cyclooxygenase (COX) enzyme. This enzymatic blockade limits the synthesis of molecular messengers, specifically prostaglandins, which are key drivers of vascular changes. Blocking this pathway modulates the effects of excessive local mediators by decreasing localized temperature and blood vessel diameter.

Modification of Epidermal Structure

The third component provides a keratolytic action, chemically acting to soften and dissolve the protein structure of the stratum corneum. This physical mechanism promotes the sloughing of excess, thickened cell layers and assists the drug molecules in crossing the skin barrier to influence deeper physiological targets.

Dosage and Administration Information

How to use Soderm plus

Soderm plus is a prescription-only topical medication containing a potent corticosteroid (Betamethasone Dipropionate) and a keratolytic agent (Salicylic Acid). Its administration is intended for localized use to minimize systemic exposure to the active ingredients. This section outlines the standard usage for the medication.

Administration and Dosing

The medication is available as an Ointment or a Cutaneous Solution (Lotion) and is Topical for external use only. It must not be used in the eyes (ophthalmic), orally, or intravaginally.

Feature	Official Usage Principle
Application Technique	Apply a thin film (ointment) or a few drops (solution) to the affected skin area.
Dosing Frequency	Typically applied once or twice daily
Administration Precaution	Rub gently into the skin. Wash hands immediately after use unless hands are the treated area.

Use Limitations and Restrictions

To control the risk of systemic absorption associated with potent corticosteroids, use is limited in duration and application site:

Duration: Therapy should be limited to a maximum of 2 consecutive weeks in adults and discontinued once satisfactory control is achieved. If no improvement is seen after this period, the diagnosis should be reassessed.
Maximum Dose: The total amount applied should not exceed 50 g or 50 mL per week (depending on the formulation) to reduce the risk of systemic effects.
Target Areas to Avoid: The preparation must not be applied to the face, groin, armpits (axillae), or other intertriginous areas.
Occlusion Rule: The treated area should not be covered with occlusive dressings (bandages or wraps) unless a healthcare professional specifically instructs it.
Pediatric Use: Use in children under 13 years of age is generally not recommended or must be strictly limited to a very short duration (e.g., 5 days) and a small treatment area.

Recent Clinical Evidence

Soderm plus, which combines the vitamin D analogue calcipotriol and the corticosteroid betamethasone dipropionate, has been the subject of numerous clinical studies focusing on the treatment of plaque psoriasis.

Efficacy in Plaque Psoriasis

Clinical trials, including randomized controlled trials (RCTs), suggest that the combination of calcipotriol and betamethasone dipropionate may offer a rapid onset of effect and significant improvements in psoriasis symptoms. Specifically:

Investigator's Global Assessment (IGA): Studies have shown that a statistically significantly higher proportion of patients receiving the combination formulation achieved 'treatment success' (defined as 'clear' or 'almost clear' skin) compared to those using the vehicle (inactive base) or either component alone.
Symptom Improvement: Pooled analyses from clinical trials indicate that the combination may improve symptoms such as itch (pruritus) and associated sleep loss, with improvements often observed as early as one week into treatment.

Formulations and Comparative Effectiveness

The combination of calcipotriol and betamethasone dipropionate is available in multiple topical formulations, including ointments, gels, and aerosol foams. Research suggests that the specific vehicle used may influence effectiveness:

Formulation Comparison	Finding Reported in Studies
Aerosol Foam vs. Ointment	In some studies, the aerosol foam formulation demonstrated a greater antipsoriatic effect compared to the ointment or gel formulations.
Combination vs. Monotherapy	Studies generally observe the combination formulation provides greater efficacy than treatment with calcipotriol or betamethasone dipropionate used as monotherapy (alone).

Safety and Tolerability Profile

Across multiple studies, the overall incidence of adverse events with the combination product was generally comparable to that observed with the individual components. The addition of calcipotriol to betamethasone dipropionate is often studied to determine if it can offer potential benefits in long-term management while limiting the duration of potent corticosteroid use. Limited systemic absorption has been noted when the product is used as directed.

Frequently Asked Questions (FAQ)

Common questions about Soderm plus (FAQ)

Q: What is Soderm plus used to treat?

A: Soderm plus is indicated for treating inflammatory skin conditions that are also complicated by a secondary infection caused by certain bacteria or fungi. According to regulatory documents, this includes conditions like eczema (atopic, infantile, and discoid), seborrhoeic dermatitis, contact dermatitis, and psoriasis.

Q: What are the active ingredients in Soderm plus?

A: The official product information states that Soderm plus contains two active components. These are betamethasone dipropionate, which is a corticosteroid, and gentamicin, which is an antibiotic. The combination of ingredients is intended to target both inflammation and certain bacterial infections, according to official information.

Q: Can Soderm plus be used for nappy rash in infants?

A: Regulatory documents advise that Soderm plus should not be used in the treatment of nappy rash in babies. This specific skin condition is excluded from the indications for which the product is approved.

Q: How long can I typically use Soderm plus for?

A: According to the official product information, Soderm plus should generally be used for a short time. Treatment duration is typically limited to a few weeks, or sometimes even shorter if the infection is controlled. Regulatory warnings emphasize avoiding the use of the product for extended periods, and any long-term use should be under the guidance of a healthcare professional.

Q: Is Soderm plus suitable for children?

A: Official information indicates that Soderm plus should be used with caution in children, particularly on large skin areas or under airtight dressings. Studies state that children may be more susceptible to absorption of the corticosteroid component. Official guidance stresses that use in children requires careful consideration and professional direction.

How should Soderm plus be stored and disposed of?

How to Store and Dispose of Soderm Plus

Official regulatory labeling dictates strict conditions for the storage and disposal of Soderm Plus (Betamethasone Dipropionate/Salicylic Acid) to maintain its stability and ensure safety.

Storage Requirements

Condition	Regulatory Requirement
Temperature	Store at room temperature, typically below 25 C or 30 C for the unopened product.
Environment	Do not freeze and keep away from heat.
Container	Keep the medicine in its original container and ensure it is tightly closed.
Child Safety	Keep this medicine out of the sight and reach of children.

Disposal Instructions

Any unused or expired Soderm Plus must not be disposed of in wastewater or household waste. Disposal must be performed in accordance with local regulatory requirements. Consult a pharmacist for instructions on properly discarding unused medication to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Germany

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z